RaySearch receives 510(k) clearance for Pencil Beam Scanning with protons
ET | Source:RaySearch Laboratories AB
In December 2013 an extended version of RaySearch’s RayStation® 4.0 treatment
planning system was CE-marked and released for clinical use to multiple markets.
The new version contained tools for optimization of proton treatments using the
pencil beam scanning technique (PBS). RaySearch has now received 510(k)
clearance for this new version, which means that this new functionality can be
sold and marketed in the US.
Proton therapy is considered the most advanced form of radiation therapy due to
its superior dose distribution and fewer side effects. Protons deposit the
majority of their energy within a precisely controlled range, thus making it
easier to target the tumor and to spare healthy surrounding tissue. PBS is the
most sophisticated technique to deliver proton therapy. It enables Intensity
Modulated Proton Therapy (IMPT) that allows clinicians to target a cancerous
tumor by controlling both the intensity and the spatial distribution with
The proton module in RayStation® contains all the state-of-the-art tools needed
for PBS such as multiple field optimization, single field uniform dose and
distal edge tracking techniques.
“We have won several orders and been the most successful supplier of solutions
for proton treatment planning over the last year. Our position on the US market
becomes even stronger now that we have market clearance for all relevant
techniques for proton therapy”, says Johan Löf, CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
photon, electron and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch provides
the RayStation® treatment planning system to clinics all over the world. In
addition, RaySearch’s products are distributed through licensing agreements with
leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date,
15 products have been launched via partners and RaySearch’s software is used by
over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a
spin-off from the Karolinska Institute in Stockholm and the company is listed in
the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-545 061 30
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.